• DOI:10.1002/ijc.29048
Corpus ID: 27535394

Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma

@article{Siurala2015OncolyticAA,
  title={Oncolytic adenovirus and doxorubicin‐based chemotherapy results in synergistic antitumor activity against soft‐tissue sarcoma},
  author={M. Siurala and Simona Bramante and L. Vassilev and M. Hirvinen and S. Parviainen and S. T{\"a}htinen and K. Guse and V. Cerullo and A. Kanerva and A. Kipar and M. V{\"a}h{\"a}-Koskela and Akseli Hemminki},
  journal={International Journal of Cancer},
  year={2015},
  volume={136}
}

M. Siurala, Simona Bramante, +9 authors Akseli Hemminki

Published 2015

Biology, Medicine

International Journal of Cancer

Despite originating from several different tissues, soft‐tissue sarcomas (STS) are often grouped together as they share mesenchymal origin and treatment guidelines. Also, with some exceptions, a common denominator is that when the tumor cannot be cured with surgery, the efficacy of current therapies is poor and new treatment modalities are thus needed. We have studied the combination of a capsid‐modified oncolytic adenovirus CGTG‐102 (Ad5/3‐D24‐GMCSF) with doxorubicin, with or without… CONTINUE READING

View on Wiley

onlinelibrary.wiley.com

Save to Library

Create Alert

Cite

Launch Research Feed